 |
In today’s hypercompetitive pharmaceutical and life sciences (PLS) industry, strategic partnerships are more critical than ever. A smaller life sciences company may have relationships with hundreds of healthcare providers and healthcare organizations. For larger manufacturers, that number can easily stretch into the tens of thousands. PwC research from early 2021 revealed that businesses overwhelmingly expect their dependence on third parties to grow, along with heightened regulatory scrutiny of third parties and an increase in third-party risks ranging from security issues to finance and compliance. In this ebook we will cover:
|
